{
  "emaEpar": [
    {
      "activeSubstance": "cabazitaxel",
      "conditionIndication": "Jevtana in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen., ",
      "inn": "cabazitaxel",
      "marketingAuthorisationDate": "2011-03-17 01:00:00",
      "marketingAuthorisationHolder": "sanofi-aventis groupe\u00a0",
      "medicineName": "Jevtana",
      "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/jevtana"
    },
    {
      "activeSubstance": "cabazitaxel",
      "conditionIndication": "Treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen., ",
      "inn": "cabazitaxel",
      "marketingAuthorisationDate": "2020-08-28 00:00:00",
      "marketingAuthorisationHolder": "Accord Healthcare S.L.U.",
      "medicineName": "Cabazitaxel Accord",
      "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/cabazitaxel-accord"
    }
  ],
  "fdaDrugLabel": [],
  "id": "Cabazitaxel",
  "nciThesaurus": {
    "casRegistry": "183133-96-2",
    "chebiId": "CHEBI:63584",
    "chemicalFormula": "C45H57NO14",
    "definition": "A semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity. Cabazitaxel binds to and stabilizes tubulin, resulting in the inhibition of microtubule depolymerization and cell division, cell cycle arrest in the G2/M phase, and the inhibition of tumor cell proliferation. Unlike other taxane compounds, this agent is a poor substrate for the membrane-associated, multidrug resistance (MDR), P-glycoprotein (P-gp) efflux pump and may be useful for treating multidrug-resistant tumors. In addition, cabazitaxel penetrates the blood-brain barrier (BBB).",
    "fdaUniiCode": "51F690397J",
    "identifier": "C66937",
    "preferredName": "Cabazitaxel",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1490",
      "C67437"
    ],
    "synonyms": [
      "1-hydroxy-7beta,10beta-dimethoxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-{[(tertbutoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoate]",
      "CABAZITAXEL",
      "Cabazitaxel",
      "Jevtana",
      "RPR-116258A",
      "Taxoid XRP6258",
      "XRP-6258",
      "cabazitaxel",
      "taxoid XRP6258"
    ]
  }
}